from page of facebook FYR
"Ashitaba - Angelica keiskei koidzumi "
--DIFFERENCE BETWEEN A. KEISKEI (ASHITABA) AND A. SINENSIS (DONG QUAI)--
As you may have already researched, Ashitaba belongs to the genus Angelica. This means there are other varieties / species of Angelica other than Ashitaba Angelica keiskei.
Recently, there were five people who were asking us how to distinguish Angelica keiskei from other Angelica varieties.
They bought "ashitaba angelica keiskei" from a plant seller, it was expensive and looked like the real one yet they're not. It also does not give out even the slightest amount or indication of chalcone. Chances are, it's Angelica sinensis as this specie almost resembles Ashitaba.
So how do we identify the real Ashitaba? Read on for some simple tips>>>
Ashitaba A. keiskei and A. sinensis are almost identical. However, if you notice, the real Ashitaba has, in 1 stem, 3 branches with 1 leaf each having another 3 connected leaves (somewhat resembles a fork), whereas in A. sinensis, its 3 branches have 1 whole leaf each.
The sides of both species (A. keiskei and A. sinensis) also have a slight difference. The A. keiskei has a fine serrated (saw-toothed like) edgeS. On the other hand, A. sinensis has a bigger serrated edges.
And the most important component which separates A. keiskei from the rest of the Angelica plants is the Chalcone. Only the real Ashitiba A. keiskei has this active component.
But the simplest way to identify a legitimate Ashitaba Angelica keiskei supplier is to ask for a Certificate of authentication if you find the plant suspicious.
It's important to be aware of even the slightest feature of the plant you desire such as identifying the real Ashitaba.
While A. sinensis also holds some medicinal values, there are also findings that it contains carcinogens, and there's a risk of drug interactions. But for A. keiskei, research and clinic trials made in Japan and US dictates that it is completely safe and has no drug interaction.
We hope this, more or less, helps clear out some confusions.
......" |